AlQteishat A, Gaffney J, Krupinski J, Rubio F, West D, Kumar S, et al
The Phase 2 trial results Published in the New England Journal of Medicine, the Phase 2 trial showed that participants receiving the highest dose of retatrutide (12mg weekly) achieved a mean weight reduction of 24.2% at 48 weeks
November 9, 2021
Rather than targeting an isolated cellular mechanism, this advanced 80,000mcg matrix integrates four highly active synthetic peptide architectures: a stable gastric pentadecapeptide, a functional thymosin beta-4 fragment, a specialized tripeptide anti-inflammatory ligand, and a potent copper-binding signaling complex
Tendons receive significantly less blood flow than muscles
Other Players in the Amylin Arena Aside from Novo, Lilly is also advancing its own suite of amylin hopefuls, the most mature of which is eloralintide, a weekly therapy being tested in combination with tirzepatide in nondiabetic obese people